10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001439222-17-000009`
Period End Date	20170930
Filing Date	20171101
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	agio-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 48 Cash Flow Statement 63 Comprehensive Income 12

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$285.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.74M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$380.56M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$375.19M	USD	Point-in-time
Collaboration receivable related party	`CollaborationReceivableDuefromRelatedPartiesCurrent`	$3.49M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Collaboration receivable related party	`CollaborationReceivableDuefromRelatedPartiesCurrent`	$4.89M	USD	Point-in-time
Royalty receivable related party	`RoyaltyReceivableDuefromRelatedPartiesCurrent`	-	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Royalty receivable related party	`RoyaltyReceivableDuefromRelatedPartiesCurrent`	$715.00K	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	48.62M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	42.22M	shares	Point-in-time
Tenant improvement and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.43M	USD	Point-in-time
Tenant improvement and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$859.00K	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	48.62M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	42.22M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$15.32M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$528.31M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$559.89M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$32.25M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$133.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$25.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$24.02M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.61M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.07M	USD	Point-in-time
Total assets	`Assets`	$619.09M	USD	Point-in-time
Total assets	`Assets`	$687.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.90M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$30.76M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$32.00M	USD	Point-in-time
Deferred revenue related party	`DeferredRevenueCurrent`	$35.87M	USD	Point-in-time
Deferred revenue related party	`DeferredRevenueCurrent`	$35.91M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$3.59M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$3.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.43M	USD	Point-in-time
Deferred revenue, net of current portion related party	`DeferredRevenueNoncurrent`	$134.20M	USD	Point-in-time
Deferred revenue, net of current portion related party	`DeferredRevenueNoncurrent`	$154.30M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$15.08M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$17.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$237.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$260.50M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 48,617,989 and 42,220,444 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 48,617,989 and 42,220,444 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$842.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.16B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-313.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-515.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-483.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-709.78M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$358.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$449.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$687.20M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$619.09M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$4.04M	USD	1 Quarter
Collaboration revenue related party	`LicenseAndServicesRevenue`	$10.64M	USD	1 Quarter
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$6.34M	USD	3 Qtrs
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$18.75M	USD	3 Qtrs
Collaboration revenue related party	`LicenseAndServicesRevenue`	$32.50M	USD	3 Qtrs
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$1.08M	USD	1 Quarter
Collaboration revenue related party	`LicenseAndServicesRevenue`	$8.98M	USD	1 Quarter
Collaboration revenue related party	`LicenseAndServicesRevenue`	$47.24M	USD	3 Qtrs
Royalty revenue related party	`RoyaltyRevenue`	$715.00K	USD	1 Quarter
Royalty revenue related party	`RoyaltyRevenue`	-	USD	3 Qtrs
Royalty revenue related party	`RoyaltyRevenue`	-	USD	1 Quarter
Royalty revenue related party	`RoyaltyRevenue`	$715.00K	USD	3 Qtrs
Total revenue	`Revenues`	$47.24M	USD	3 Qtrs
Total revenue	`Revenues`	$8.98M	USD	1 Quarter
Total revenue	`Revenues`	$11.36M	USD	1 Quarter
Total revenue	`Revenues`	$33.21M	USD	3 Qtrs
Research and development (net of $2,776 and $8,794 of cost reimbursement from related party for the three months ended March 31, 2017 and 2016, respectively)	`ResearchAndDevelopmentExpense`	$215.47M	USD	3 Qtrs
Research and development (net of $2,776 and $8,794 of cost reimbursement from related party for the three months ended March 31, 2017 and 2016, respectively)	`ResearchAndDevelopmentExpense`	$60.64M	USD	1 Quarter
Research and development (net of $2,776 and $8,794 of cost reimbursement from related party for the three months ended March 31, 2017 and 2016, respectively)	`ResearchAndDevelopmentExpense`	$155.49M	USD	3 Qtrs
Research and development (net of $2,776 and $8,794 of cost reimbursement from related party for the three months ended March 31, 2017 and 2016, respectively)	`ResearchAndDevelopmentExpense`	$72.92M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$17.46M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$35.34M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$48.41M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$11.85M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$263.88M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$190.82M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$72.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$90.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-63.51M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-230.66M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-79.02M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-143.58M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$678.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.88M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$4.28M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.59M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-62.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-226.38M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-141.99M	USD	3 Qtrs
Net (loss) income per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.59	USD	1 Quarter
Net (loss) income per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-4.94	USD	3 Qtrs
Net (loss) income per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-3.72	USD	3 Qtrs
Net (loss) income per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.63	USD	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.46M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	45.85M	shares	3 Qtrs
Weighted-average number of common shares used in computing net (loss) income per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	38.55M	shares	1 Quarter
Weighted-average number of common shares used in computing net (loss) income per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	38.12M	shares	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-62.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-226.38M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-141.99M	USD	3 Qtrs
Depreciation	`Depreciation`	$3.99M	USD	3 Qtrs
Depreciation	`Depreciation`	$4.78M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$35.13M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$32.25M	USD	3 Qtrs
Net amortization of premium and discounts on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-25.00K	USD	3 Qtrs
Net amortization of premium and discounts on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-534.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets1`	$-40.00K	USD	3 Qtrs
Collaboration receivable related party	`IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent`	$-43.00K	USD	3 Qtrs
Collaboration receivable related party	`IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent`	$-1.40M	USD	3 Qtrs
Royalty receivable related party	`IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent`	-	USD	3 Qtrs
Royalty receivable related party	`IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent`	$715.00K	USD	3 Qtrs
Tenant improvement and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.56M	USD	3 Qtrs
Tenant improvement and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-271.00K	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.44M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.46M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.67M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$742.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.24M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$7.33M	USD	3 Qtrs
Deferred revenue related party	`IncreaseDecreaseInDeferredRevenue`	$185.99M	USD	3 Qtrs
Deferred revenue related party	`IncreaseDecreaseInDeferredRevenue`	$-20.14M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-2.17M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$2.52M	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-210.78M	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$89.78M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$367.59M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$604.52M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$334.45M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$508.12M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.69M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.35M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-41.83M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-99.76M	USD	3 Qtrs
Payment of public offering costs, net of reimbursements	`PaymentsOfStockIssuanceCosts`	$124.00K	USD	3 Qtrs
Payment of public offering costs, net of reimbursements	`PaymentsOfStockIssuanceCosts`	$89.00K	USD	3 Qtrs
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$162.15M	USD	3 Qtrs
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$270.25M	USD	3 Qtrs
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$270.20M	USD	Point-in-time
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$3.76M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.36M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$282.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$165.78M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$213.74M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-28.01M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$285.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$71.76M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$132.74M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$285.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$71.76M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$132.74M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$497.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$226.00K	USD	3 Qtrs
Proceeds from stock option exercises in other receivables	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	$95.00K	USD	3 Qtrs
Proceeds from stock option exercises in other receivables	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	-	USD	3 Qtrs
Public offering costs in other receivables, net of amounts in accounts payable and accrued expenses	`PublicOfferingCostsInOtherCurrentAssets`	$124.00K	USD	3 Qtrs
Public offering costs in other receivables, net of amounts in accounts payable and accrued expenses	`PublicOfferingCostsInOtherCurrentAssets`	$318.00K	USD	3 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-62.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-226.38M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-141.99M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$135.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$347.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-268.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-202.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-141.64M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-226.59M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-63.10M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-77.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.